Pramipexole for Sleep Disorders and Parkinson's Disease
Clinical Applications
- The American Academy of Sleep Medicine suggests against the standard use of pramipexole for Restless Legs Syndrome (RLS) due to moderate certainty of evidence, but may be considered for patients who prioritize short-term symptom relief over long-term adverse effects 1, 2, 3
- The American Academy of Sleep Medicine suggests pramipexole as a conditional treatment option for isolated REM Sleep Behavior Disorder (RBD) in adults, particularly those with elevated periodic limb movements on polysomnography 4, 5
Adverse Effects
- Pramipexole use is associated with impulse control disorders, such as pathological gambling, hypersexuality, and compulsive shopping, according to the American Academy of Sleep Medicine 3
- Dopaminergic agonists like pramipexole may exacerbate symptoms of Dementia with Lewy Bodies (DLB), as reported by the American Academy of Sleep Medicine 7, 8
- Long-term use of pramipexole in RLS can lead to augmentation, characterized by worsening of symptoms, earlier onset, and spread to other body parts, as noted by the American Academy of Sleep Medicine 3